To be honest 40% profit margin is super high for any industry.
Any idea, why no big pharma think of getting into this industry? Fairly low entry requirements.
- cost is relatively low compare to R & D for a new drug - set the whole thing up less than 12 months, if IHL can do it, I don't see why big pharma can't - just need to hire someone who can authorise the use of MDMA - hire someone reputable and qualified to oversee the project - find supplier for the drug
Sorry for playing devil advocate here. But as someone so sensitive to number, 40% net profit margin is like a dream.
IHL Price at posting:
11.5¢ Sentiment: None Disclosure: Not Held